Atossa Therapeutics
ATOS
#10766
Rank
A$28.13 M
Marketcap
A$2.82
Share price
-1.55%
Change (1 day)
133.11%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -A$55.62 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$51.59 Million a decrease over its 2024 earnings that were of -A$37.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$55.62 Million7.81%
2025 -A$51.59 Million36.33%
2024 -A$37.84 Million-15.25%
2023 -A$44.65 Million11.62%
2022 -A$40 Million30.84%
2021 -A$30.58 Million15.58%
2020 -A$26.45 Million3.41%
2019 -A$25.58 Million51.16%
2018 -A$16.93 Million40.41%
2017 -A$12.06 Million27.54%
2016 -A$9.45 Million-47.49%
2015 -A$18 Million-17.25%
2014 -A$21.75 Million35.91%
2013 -A$16.01 Million112.3%
2012 -A$7.54 Million46.53%
2011 -A$5.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.77 B-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$2.21 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$2.15 B-3,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$61.83 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-A$48.87 Million-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-A$11.64 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA